- Coordinator
- Helsingin Yliopisto, Finland
- Runs
- 1 December 2026 to 30 November 2031
- Status
- Running
- EU funding
- €2.5m
- Total cost
- —
- Partners
- 1 organisations in 1 countries
- Type
- European Research Council grant
- Grant agreement
- 101265774
What the project is doing
In the project's own words, from its summary on CORDIS.
An effective, well-regulated immune response is crucial for defending against infections and disease. Normally, inflammation is transient and resolves as healing occurs; however, failure to resolve leads to chronic inflammation, causing persistent immune activation and disrupted tissue architecture and function. A critical but understudied player in this process is the lymphatic vasculature, which is not only a conduit for immune cells but also a local immune modulator.
Lymphatic endothelial cells (LECs), positioned at sites of tissue injury, infection and in lymph nodes, regulate immune dynamics by guiding immune cell trafficking, presenting antigens, and shaping local inflammatory niches. Building on our discovery of a molecularly distinct, Ptx3+ immune-interacting LEC subtype at lymphatic capillary terminals, and emerging evidence of durable inflammation-driven lymphatic remodeling, I hypothesize that LECs acquire an ‘inflammatory memory’ that affects secondary immune activation and persistence of inflammation.
To define how LECs are shaped by, and in turn regulate, inflammation and whether they can be therapeutically reprogrammed to restore tissue homeostasis, we will: (1) determine the origins, clonal structure, long-term fate, and molecular properties of LECs expanded during inflammation using in vivo models, advanced imaging, and state-of-the-art molecular and genetic tools; (2) uncover LEC-dependent mechanisms controlling the formation, composition, and maintenance of tertiary lymphoid structures (TLSs) in inflamed tissues; and (3) utilize targeted gene-delivery platforms and spiny mouse as a unique scar-free regeneration model to identify and test strategies that modulate LEC-intrinsic pathways to control TLS persistence, and promote inflammation resolution and tissue repair.
This work will uncover fundamental principles of lymphatic–immune crosstalk and open avenues for precise, tissue-specific immune regulation in inflammatory disease.
Topics
Who is involved
| Organisation | City | Country | Role |
|---|---|---|---|
| Helsingin Yliopisto | Helsinki | Finland | Coordinator |
Source: CORDIS, European Commission. Data of 5 Nov 2026, reused under the Commission's reuse policy. View on CORDIS · Grant DOI